TODOERTI, MONICA
 Distribuzione geografica
Continente #
NA - Nord America 343
AS - Asia 305
EU - Europa 198
SA - Sud America 18
AF - Africa 1
Totale 865
Nazione #
US - Stati Uniti d'America 342
CN - Cina 174
SG - Singapore 71
IE - Irlanda 65
DE - Germania 34
FI - Finlandia 33
HK - Hong Kong 32
RU - Federazione Russa 31
VN - Vietnam 16
BR - Brasile 15
AT - Austria 11
GB - Regno Unito 7
NL - Olanda 4
CZ - Repubblica Ceca 3
IN - India 3
PL - Polonia 3
BD - Bangladesh 2
IT - Italia 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
CA - Canada 1
EC - Ecuador 1
ES - Italia 1
IL - Israele 1
JP - Giappone 1
MA - Marocco 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
SE - Svezia 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 865
Città #
Dublin 65
Chandler 56
Ashburn 41
Beijing 35
Singapore 35
Hong Kong 32
Jacksonville 31
Nanjing 31
Dallas 25
Helsinki 24
Nanchang 17
Changsha 15
Munich 15
Los Angeles 14
Hebei 12
Shenyang 12
Boardman 11
Lawrence 11
Medford 11
Princeton 11
Vienna 9
Shanghai 8
Ho Chi Minh City 6
Redondo Beach 6
Wilmington 6
Hangzhou 5
Moscow 5
Tianjin 5
Amsterdam 4
Buffalo 4
Falkenstein 4
New York 4
Chicago 3
Denver 3
Hanoi 3
Jiaxing 3
Santa Clara 3
Warsaw 3
Washington 3
Ankara 2
Brno 2
Fremont 2
London 2
Ningbo 2
Pavia 2
Poplar 2
San Francisco 2
Seattle 2
Sorocaba 2
Agadir 1
Alvorada 1
Andover 1
Ann Arbor 1
Atlanta 1
Bangalore 1
Biên Hòa 1
Blackwood 1
Boston 1
Brasília 1
Bratislava 1
Brooklyn 1
Chennai 1
Córdoba 1
Duque de Caxias 1
Esslingen am Neckar 1
Estância Velha 1
Fairfield 1
Glenn Dale 1
Guarulhos 1
Haikou 1
Haiphong 1
Honolulu 1
Imbé 1
Itabela 1
Jardinópolis 1
Jimei 1
Jinan 1
Kandalaksha 1
Lima 1
Lynn 1
Manila 1
Mcallen 1
Newark 1
Nilópolis 1
Norwalk 1
Nuremberg 1
Orem 1
Phoenix 1
Prague 1
Pune 1
Qingdao 1
Quevedo 1
Quận Hai 1
Raleigh 1
Rio de Janeiro 1
San Jose 1
Secaucus 1
Serra Talhada 1
Shantou 1
Stockholm 1
Totale 662
Nome #
20 years of experience with tumour necrosis factor inhibitors: what have we learned? 107
Biosimilars: Lights and shadows in rheumatology 92
Glucocorticoids in rheumatoid arthritis 87
Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs 82
Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease in a cohort of patients treated with TNF-alpha inhibitors 80
Drug survival of the first course of anti-TNF agents in patients with rheumatoid arthritis and seronegative spondyloarthritis: Analysis from the monitornet databas 76
The role of low-dose glucocorticoids for rheumatoid arthritis in the biologic era 70
Low risk of hepatitis B virus reactivation in HBsAg-negative/anti-HBc-positive carriers receiving rituximab for rheumatoid arthritis: A retrospective multicenter Italian study 70
Systematic review of 2008-2012 literature and update of recommendations for the use of methotrexate in rheumatic diseases, with a focus on rheumatoid arthritis 67
Switching from intravenous to subcutaneous formulation of abatacept: Different results in a series of 21 patients 63
Methotrexate and Rheumatoid Arthritis: Current Evidence Regarding Subcutaneous Versus Oral Routes of Administration 63
Power Doppler ultrasonographic assessment of the joint-draining lymph node complex in rheumatoid arthritis: a prospective, proof-of-concept study on treatment with tumor necrosis factor inhibitors 36
Totale 893
Categoria #
all - tutte 4.320
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.320


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117 0 0 0 0 0 2 0 8 0 7 0 0
2021/202240 0 0 0 0 0 0 1 1 2 0 8 28
2022/2023159 16 17 3 7 13 18 0 8 70 3 4 0
2023/202480 15 18 7 4 4 15 0 7 1 5 2 2
2024/2025186 6 12 3 2 3 21 8 14 52 3 17 45
2025/2026231 46 23 45 46 59 12 0 0 0 0 0 0
Totale 893